pI: 6.7307 |
Length (AA): 203 |
MW (Da): 23003 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_130173)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G63400 | cyclophilin-like peptidyl-prolyl cis-trans isomerase family protein |
Arabidopsis thaliana | AT4G32420 | cyclophilin-like peptidyl-prolyl cis-trans isomerase family protein |
Caenorhabditis elegans | CELE_D1009.2 | Protein CYN-8, isoform A |
Dictyostelium discoideum | DDB_G0279491 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1866 | CG1866 gene product from transcript CG1866-RC |
Echinococcus granulosus | EgrG_001194300 | peptidyl prolyl isomerase G |
Echinococcus multilocularis | EmuJ_001194300 | peptidyl prolyl isomerase G |
Homo sapiens | ENSG00000114857 | natural killer cell triggering receptor |
Homo sapiens | ENSG00000138398 | peptidylprolyl isomerase G (cyclophilin G) |
Mus musculus | ENSMUSG00000032525 | natural killer tumor recognition sequence |
Mus musculus | ENSMUSG00000042133 | peptidyl-prolyl isomerase G (cyclophilin G) |
Schistosoma japonicum | Sjp_0303590 | expressed protein |
Schistosoma japonicum | Sjp_0013430 | ko:K09566 peptidyl-prolyl isomerase G (cyclophilin G), putative |
Schistosoma mansoni | Smp_069160.1 | peptidyl-prolyl cis-trans isomerase G ppig |
Schistosoma mansoni | Smp_069160.2 | peptidyl-prolyl cis-trans isomerase G ppig |
Trichomonas vaginalis | TVAG_277390 | peptidyl-prolyl cis-trans isomerase A, ppia, putative |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | peptidylprolyl isomerase G (cyclophilin G) | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Cyclophilin A | 164 aa | 57.1% | 168 aa | Compounds | References |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase | 171 aa | 61.0% | 172 aa | Compounds | References |